Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Hikma Pharmaceuticals (HIK.LSE) Q3 2024 Earnings
HIK.LSE
-1.81%
8
Aug
Confirmed
Q4 2022
Q2 2023
Q1 2024
Q3 2024
0.91
33.82
66.73
99.63
Details
Expected EPS
N/A
Actual EPS
99.63404
Surprise EPS
99.63
Surprise Percent
+∞%
Description
Hikma Pharmaceuticals (HIK.LSE) has reported earnings of 99.63404 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login